Raimundo Nonato Delgado‑Rodrigues

Raimundo Nonato Delgado‑Rodrigues


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Sleep Science
Verified
Journal Article
Open access
RDRaimundo Nonato Delgado‑Rodrigues
Raimundo Nonato Delgado‑Rodrigues
This review concerns the first systematic work on REM Behavior Disorder (RBD) etiology, physiopathology, diagnosis, clinical management, as well as new trends on genetic research. It represents massive expert cooperation involving multinational specialists and provides a valuable tool for further comprehension of this sleep condition.

1 July 2019 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
CTCarlos B. Tauil
Carlos B. Tauil
FGFelipe von Glehn
Felipe von Glehn
RDRaimundo Nonato Delgado‑Rodrigues
Raimundo Nonato Delgado‑Rodrigues
JGJaqueline R.A.A. Gomes
Jaqueline R.A.A. Gomes
CBCarlos O. Brandão
Carlos O. Brandão
LSLeopoldo L. dos Santos-Neto
Leopoldo L. dos Santos-Neto
Neuropsychiatric disorders in multiple sclerosis have been known since the original clinicopathological description by Charcot in the late nineteenth century. Charcot, in the last decades of his life, became involved in the field of neuropsychiatry. This produced a battle between rival schools in the era that still echoes to this day. Charcot’s intuition, including the line of thought of Babinski, one of his most famous disciples, was that there was a connection between mood disorders and many of the diseases of the nervous system. Medicine’s concern with establishing a relationship between mood disorders and disease stems from the ancient and middle ages with references found in the Hippocratic doctrine. However, it was only in the second half of the nineteenth and early twentieth century, with Charcot’s discoveries, that this discussion was established in a structured way, laying the foundations of neuropsychiatry.

15 January 2025 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
DMDébora Palma Maia
Débora Palma Maia
RCRubens Gisbert Cury
Rubens Gisbert Cury
Pedro Renato de Paula BrandãoPedro Renato de Paula Brandão
Pedro Renato de Paula Brandão
FCFrancisco E. C. Cardoso
Francisco E. C. Cardoso
ABAna Paula Bertholo
Ana Paula Bertholo
RSRoberta Arb Saba
Roberta Arb Saba
The treatment of Parkinson's disease (PD) is a challenge, especially because it is considered highly individualized. The Brazilian Academy of Neurology (ABN) has identified the need to disseminate knowledge about its management, adapting the best evidence to the Brazilian population. The present article aims to report the recommendations for the treatment of non-motor symptoms of PD, developed by a group of specialists in movement disorders from the ABN's scientific department. In 2021, the first part, referring to the motor symptoms of PD, was published. The main non-motor symptoms were addressed—among them neuropsychiatric symptoms, such as depression, anxiety, cognitive alteration, and psychosis—as well as the possible recommended therapies and medications used to control pain, sleep disorders, and dysautonomia.

1 January 2020 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
RDRaimundo Nonato Delgado‑Rodrigues
Raimundo Nonato Delgado‑Rodrigues
In September 1939, World War II broke out and the French government called for a general mobilization. In 1940, Rohmer had the opportunity to study for a short time with Prof. Théophile Alajouanine2. With the German invasion, the latter young doctor was subsequently conscripted into the army medical corps, participated in the ill-fated Ardennes Campaign and became a prisoner of war.

1 June 2026 in Sleep Science
Verified
Journal Article
Open access
Maria-Cecilia LopesMaria-Cecilia Lopes
Maria-Cecilia Lopes
LHLucio Huebra
Lucio Huebra
GPGilmar Fernandes do Prado
Gilmar Fernandes do Prado
SSSuzana Veiga Schonwald
Suzana Veiga Schonwald
RARosana Cardoso Alves
Rosana Cardoso Alves
PMPaulo Afonso Mei
Paulo Afonso Mei
Adapting the American Academy of Sleep Medicine (AASM) Guidelines for restless legs syndrome (RLS) to Latin America is a complex challenge, given the region's 33 countries and vast socioeconomic diversity. Such an endeavor requires comprehensive data and consensus from a broader representation of these populations. There is a need to assess the effect of social vulnerability on the prevalence of symptoms of periodic leg movements that may be erroneously called RLS and mimic the primary nosological diagnosis for itself. We aim to discuss the Asociación Lationoamericana de Sueño's (Latin American Sleep Association, ALADS, in Spanish) position statement to contextualize the 2025 AASM clinical practice guidelines for the treatment of RLS and periodic limb movement disorder. Their intention of advocating for future systematic studies employing standardized criteria in Latin America. While the Scientific Committee for Sleep Disorders of the Brazilian Academy of Neurology partially endorses those opinions, offering some counterpoints concerning, especially, the following issues: 1) challenges to the reportedly wide variability in Latin American RLS prevalence, with apparently very high prevalences exceeding the expected values in some locations; 2) the importance of complementing clinical history with structured RLS diagnostic questionnaires; and 3) amendments to the proposed summary of treatment recommendations, particularly regarding Iron supplementation. Finally, the presence of comorbidities and RLS in epidemiological studies must be considered and data from Latin America can contribute to the discussion on global criteria applied worldwide for RLS that need to be revised according to regional, social, and cultural issues.